To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Home Infusion Therapy market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global Home Infusion Therapy market size was valued at US$ 31 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 8.6% from 2022 to 2032.
Infusion Pumps is expected to be the highest revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 301 Billion during 2022 – 2032.
Report Attributes |
Details |
Forecast Period |
2022-2032 |
Historical Data Available for |
2017-2021 |
Global Market Growth Rate (2023 to 2033) | 8.6% CAGR |
Market Size in 2021 | US$ 31 Billion |
Europe Market Growth Rate (2022 to 2032) | 8.7% CAGR |
Key Market Segments Covered |
|
Key Companies Profiled |
|
As per the Home Infusion Therapy industry research by Fact.MR - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Home Infusion Therapy industry increased at around 7.6% CAGR.
The availability and capabilities of care professionals, professional education, transparency about the quality of care, and remote patient management, the innovation in technology in intravenous devices, as well as the increased prevalence of chronic illnesses, are projected to propel the market forward. Owing to this, Home Infusion Therapy market is projected to grow at a CAGR of 8.6% over the coming 10 years.
Continuous advancements in home infusion therapy, including the availability of care workers, remote patient management and transparency about the quality of care, has been assisting the industry growth ahead.
Rapid technical improvements in intravenous equipment, as well as favourable government laws for older people, have boosted demand for home infusion therapy devices, which has had a substantial influence on market growth. Furthermore, the rising incidence of chronic diseases including cardiovascular disease, orthopaedic disease, diabetes, and cancer, among others, is expected to boost the market ahead.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
North America dominated the market in 2021, with a revenue share of over 40%, and this trend is expected to continue throughout the forecast period. This can be attributed to increasing R&D in the region as well as greater utilisation of new infusion pump technology.
Increased demand for long-term therapy for people with certain conditions is driving the regional market. The development of alternative healthcare venues and home infusion services, as well as a movement in preference from acute care to home care settings due to reduced costs and more patient mobility, will propel this industry forward in the future years.
The increased need for infusion therapies in the U.S. has resulted in its global dominance in the market. The provision of patient care outside of medical settings has grown considerably in the U.S. The country's elderly population contributes significantly to this trend.
Healthcare organizations in the country are gradually switching the patient care to homecare settings in order to save money and resources. Public health officials in the U.S. have launched a variety of campaigns to promote awareness about homecare. Due to a variety of payment schemes for medical equipment, the home infusion therapy industry in the country has grown in leaps and bounds.
The increased acceptance of non-hospital operations, as well as a huge base of geriatric customers who require infusion therapies on a regular basis, are further driving demand for home infusion therapy equipment in the U.S.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Due to the multiple benefits they offer in intravenous therapy, infusion pumps accounted for more than half of the home infusion therapy market share in 2021, with a market value of US$ 16.5 Bn. Infusion pumps provide fluids, such as nutrients or medications to a patient's body in a regulated manner. They can be used to treat a number of chronic conditions, including insulin pumps, implanted pumps, and mobile chemotherapy pumps.
Companies in the market are also focusing on developing breakthrough portable and innovative infusion pumps that are essential for medical and therapeutic treatments. Other factors, such as the increasing prevalence of chronic illnesses, the ageing population, and affordable pricing, are likely to drive the growth of this segment forward.
The Covid-19 pandemic benefited the home infusion market since the method of home infusion was in high demand because to the overcrowding of healthcare institutions with Covid patients.
The regional and national lockdowns had a significant impact on operations and supply chains, however, the market developed dramatically in 2020. According to Medtech Dive, Baxter reported third-quarter sales of US$ 2.97 Billion in October 2020, up 4% from the previous year, owing to higher demand for COVID-related medical equipment. In addition, Baxter reported a 6% rise in operating revenue equated to US$ 3.2 Billion in Q3 2021, compared to US$ 3 Billion in Q3 2020, demonstrating the pandemic recovery's continued impact.
CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd. are some of the key players in the global home infusion therapy market. One of the key factors boosting industry rivalry among market rivals is the rapid use of contemporary healthcare technologies for improved healthcare services.
To retain market share and broaden their product range, significant players commonly adopt techniques such as mergers, acquisitions, and new product releases.
Some of the recent developments of key Home Infusion Therapy providers are as follows:
Similarly, recent developments related to companies offering Home Infusion Therapy have been tracked by the team at Fact.MR, which are available in the full report.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
- Related Reports -
The global Home Infusion Therapy market is worth US$ 31 Bn at present.
Value of Home Infusion Therapy are projected to increase at a CAGR of around 8.6% during 2022– 2032.
Value of Home Infusion Therapy increased at a CAGR of around 7.6% during 2017 – 2021.
Patients with weakened immune systems, children, and the ageing population, as well as a high prevalence of chronic diseases, are some of the key trends driving the home infusion treatment industry.
The top 5 countries in home infusion therapy market include U.S., Germany, U.K., Japan, and China
North America accounted for over 40% of Global Home Infusion Therapy demand in 2021.
The European market for Home Infusion Therapy is projected to expand at a CAGR of around 8.7% during 2022 – 2032.
While the market in South Korea is expected to grow at nearly 9.6%, the market in Japan is projected to register a CAGR of nearly 10.4% during 2022 - 2032.